Josef H. Von Rickenbach

Josef H.
Von Rickenbach was the founder of PAREXEL International Corp., founded in 1982, where the title held was Chairman in 2018.
Mr. Von Rickenbach is the founder of Helio Vision, Inc., founded in 2016, where the title held was President & Chief Executive Officer from 2016 to 2019.
Current jobs include Chairman at Rein Therapeutics, Inc. since 2023, Chairman at Zageno, Inc. since 2019, Director at New England Healthcare Institute, Director-Health Policy & Management Executive at Harvard T.H.
Chan School of Public Health, Managing Director at Stet Vision LLC since 2018, Director at Javara, Inc., Senior Advisor at General Atlantic LP, Trustee at McLean Hospital, Inc., Board Observer at Breton Capital Management LLC, and Trustee at McLean HealthCare, Inc. Former jobs include Chairman at Association of Clinical Research Organizations from 2005 to 2014, Director at PAREXEL International Ltd., Independent Director at NextGen Acquisition Corp., Independent Director at NextGen Acquisition Corp.
II, and Manager at Enseco Energy Services Corp.
Education includes undergraduate studies at Lucerne University of Applied Sciences & Arts and an MBA from Harvard Business School.